Argenta today announced that Alastair Hay will join the company as its new Chief Financial Officer (CFO), effective 2 January 2024. To ensure a smooth transition, Alastair will work closely with former CFO Paul Fry over the coming weeks.
Prior to joining Argenta, Alastair was CFO of Pharmanovia, a speciality pharmaceutical business that manages a broad range of branded medicines across 140 markets. As one of the founding members of the company, he helped grow the business over a seven-year period to €300m in revenue and 300 employees across 10 offices globally.
Before Pharmanovia, Alastair was a Managing Director at FTI Consulting, a market-leading restructuring and debt advisory business.
Importantly, for his new role, Alastair brings a wealth of experience working in private equity environments, and his deep domain expertise will be a strong advantage for Argenta as the company continues to deliver on its ambitious growth plans.
Will Downie, CEO of Argenta, said: “I am delighted to welcome Alastair to Argenta. His proven track record and extensive experience in the private equity sector, combined with his strategic financial expertise, will have a significant impact on our business. I am excited to partner with Alastair as we continue to drive long-term growth and scale and deliver trusted, innovative ‘molecule to market’ solutions to our customers.”
“I would also like to take this opportunity to express my gratitude to Paul Fry for his significant contribution to Argenta over the last 18 months. He has played a critical role in the company’s growth, including the acquisition of three businesses, and guided major improvements across our Finance function to set us up for future success.”
Alastair Hay said: “It is an exciting time to enter the animal health industry and I am delighted to be joining Argenta. The company has a unique position in the market, and I look forward to working with the Executive Team and Board Members to create enduring value for the company, our customers, and wider stakeholders.”
Alastair qualified as a Chartered Accountant (ACA) and Corporate Treasurer (AMCT) with KPMG in London and graduated from Cambridge University.
Argenta is a global animal health services company, supporting companies big and small to develop and manufacture products that contribute to the health and wellbeing of pets and farm animals. Founded in 2006, we are the only combined global contract research organisation (CRO) and contract development and manufacturing organisation (CDMO) dedicated to animal health. From molecule to market, our trusted, innovative solutions cover every stage of product development, spanning pharmaceutical sciences, novel drug delivery technologies, (pre-)clinical and regulatory services, and manufacturing. We’re trusted by the majority of the world’s top 10 animal health companies and customers return to Argenta for our unparalleled, comprehensive support. With bases in New Zealand, the US and Europe, our 650 colleagues are driven by our partnership approach and purpose: Healthy Animals. Let’s Make It Happen, Together. For more information, please visit www.argentaglobal.com.
Annemieke de Keijzer